These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 26569109)

  • 1. Recommendations on Quality Control and Quality Assurance in Cervical Cytology.
    Branca M; Longatto-Filho A
    Acta Cytol; 2015; 59(5):361-9. PubMed ID: 26569109
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quality assurance in cervical cytology. The Papanicolaou smear. Council on Scientific Affairs.
    JAMA; 1989 Sep 22-29; 262(12):1672-9. PubMed ID: 2671421
    [No Abstract]   [Full Text] [Related]  

  • 3. [The role of benchmarking seen from the perspective of the Federal Joint Committee (G-BA)].
    Siebig J
    Z Evid Fortbild Qual Gesundhwes; 2011; 105(5):408-11. PubMed ID: 21767803
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cervical cytology EQA--the Northern experience.
    Llewellyn H
    Cytopathology; 2001 Aug; 12(4):272-3. PubMed ID: 11512548
    [No Abstract]   [Full Text] [Related]  

  • 5. A selection of monitoring parameters for gynecologic cytology-Beacons of light for quality assurance.
    Auger M
    Cancer Cytopathol; 2014 Jan; 122(1):3-4. PubMed ID: 24203215
    [No Abstract]   [Full Text] [Related]  

  • 6. Educational needs and causes of false diagnosis of atypical squamous cells of unknown significance at a university hospital.
    Kumar N; Sayed S; Moloo Z
    Afr J Reprod Health; 2011 Mar; 15(1):113-6. PubMed ID: 21987946
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Internal quality assurance in cervical cytology one laboratory's experience.
    Cross PA
    Cytopathology; 1996 Feb; 7(1):25-31. PubMed ID: 8833871
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quality control in cytopathology applied to screening for cervical carcinoma.
    Marsan C
    Pol J Pathol; 1995; 46(4):245-8. PubMed ID: 8713292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The challenge of quality improvement with the Papanicolaou smear.
    Kline TS
    Arch Pathol Lab Med; 1997 Mar; 121(3):253-5. PubMed ID: 9111111
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytopathology laboratory improvement programs of the College of American Pathologists: Laboratory Accreditation Program (CAP LAP) and Performance Improvement Program in Cervicovaginal Cytology (CAP PAP).
    Nielsen ML
    Arch Pathol Lab Med; 1997 Mar; 121(3):256-9. PubMed ID: 9111112
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Implementation and evaluation of a national external quality control program for cervical cytology in Mexico.
    Flisser A; García-Malo F; Canepa Mde L; Doncel S; Espinoza R; Moreno R; Avila I; Pérez-Palacios G; Tapia-Conyer R; de la Fuente JR
    Salud Publica Mex; 2002; 44(5):431-6. PubMed ID: 12389486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Technical proficiency in cytopathology: assessment through external quality assurance.
    Cummings MC; Greaves J; Shukor RA; Perkins G; Ross J
    Cytopathology; 2017 Apr; 28(2):149-156. PubMed ID: 27678252
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [An operative model: verification of the quality of the screening Pap test ].
    Montanari GR; Arnaud S; Berardengo E; Campione D; Cozzani C; Parisio F; Viberti L; Ghiringhello B
    Pathologica; 2001 Oct; 93(5):609-10. PubMed ID: 11725370
    [No Abstract]   [Full Text] [Related]  

  • 14. Quality and liability issues with the Papanicolaou smear: the problem of definition of errors and false-negative smears.
    Davey DD
    Arch Pathol Lab Med; 1997 Mar; 121(3):267-9. PubMed ID: 9111115
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intralaboratory reproducibility of cervical cytology diagnoses in the external quality assurance scheme of the Emilia-Romagna region of Italy.
    Sama D; Cotignoli T; Guerrini L; Maioli P; Sintoni C; Bucchi L
    Gynecol Oncol; 1996 Mar; 60(3):404-8. PubMed ID: 8774647
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The gynecologist's perspective of liability and quality issues with the Papanicolaou smear.
    Greer BE
    Arch Pathol Lab Med; 1997 Mar; 121(3):246-9. PubMed ID: 9111109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. On the "Irreducible false negative rate" in cervical cytology.
    Hutchinson ML
    Diagn Cytopathol; 1995 Aug; 13(2):179-80. PubMed ID: 8542802
    [No Abstract]   [Full Text] [Related]  

  • 18. [Guidelines for the evaluation of internal quality control of smears for screening of uterine cancer in France in the structures of Pathologic Anatomy and Cytology. French Association for Quality Assurance in Pathologic Anatomy and Cytology (AFAQAP)--Commission for cervical smears].
    Albuisson F; Anger E; Baron V; Cartier I; Dorne H; Dubois-Gordeff A; Hassoun J; Jouannelle A; Labbé S; Locquet D; Marsan C; Martin E; Michiels-Marzias D; Molinié V; Mottot C; Mueller B; Vacher-Lavenu MC; Vincent S; Vuong PN
    Ann Pathol; 1998 Jul; 18(3):221-6. PubMed ID: 9750045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Experience in implementing a quality management system in a tuberculosis laboratory, Kisumu, Kenya.
    Musau S; McCarthy K; Okumu A; Shinnick T; Wandiga S; Williamson J; Cain K
    Int J Tuberc Lung Dis; 2015 Jun; 19(6):693-5. PubMed ID: 25946361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. How expert are the experts? Implications for proficiency testing in cervicovaginal cytology.
    Ducatman BS; Ducatman AM
    Arch Pathol Lab Med; 2005 May; 129(5):604-5. PubMed ID: 15859628
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.